Update on malaria protection for short-term travellers;Nouveautés concernant la prévention médicamenteuse du paludisme pour les séjours de courte durée

Medecine et Hygiene

Volumn 55, Issue 2165, 1997, Pages 1121-1124

  Hatz, Ch ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZITHROMYCIN; CHLOROQUINE; DOXYCYCLINE; MEFLOQUINE; PRIMAQUINE; PROGUANIL;

DRUG EFFICACY; EDUCATION; HUMAN; MALARIA; PATIENT INFORMATION; RISK BENEFIT ANALYSIS; SHORT SURVEY; TRAVEL;

EID: 0030906929     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hatz C, et al. Prophylaxie du paludisme pour les séjours de courte durée. Maladies Infectieuses: diagnostic et prévention. Office fédéral de la santé publique 1994; (Suppl. 1): 1-7.
2. Steffen R, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993; 341: 1299-303.
3. Lobel HO, et al. Effectiveness and tolerance of longterm malaria prophylaxis with mefloquine - need for a better dosing regimen. JAMA 1991; 265: 361-4.
4. Phillips MA, Kass RB. User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis. I Trav Med 1996; 3: 40-5.
5. Mittelholzer ML, et al. Malaria prophylaxis in différent age groups. Proceedings of the Fourth International Conference on Travel Medicine. Acapulco, 1995.
6. Barrett J, et al. Comparison of adverse effects associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxie: Postal and telephone survey to travellers. BMJ 1996; 313:525-8.
7. Schlagenhauf P, et al. Mejloquine tolerability during chemoprophylaxis: Focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health 1996; 1: 485-94.
8. Hansford CH. Malaria prophylaxie dosage. Lancet 1995; 345: 1049.
9. Bondreau E, et al. Tolerance of prophylactic Lariam® regimens. Proceedings of the 13th International Conference on Tropical Medicine and Malaria, Pattaya, 1992: 150.
10. Assan R, et al. Mefloquine-associated hypoglycaemia in a cachectic AIDS patient. Diabete Metab 1995; 21: 54-8.
11. Thürlimann T, Osterwalder J, Verzögert eine Prophylaxe mit Mefloquin die Diagnose von Malaria tropica ? Schweiz Med Wschr 1990; 120 (Suppl.32/1): 7.
12. Day JH, Behrens RH. Delay in onset of malaria with meflquine prophylaxie. Lancet 1995; 345: 398.
13. Fryauff D, et al. Randomised placebo controlled trial of primaquine for prophylaxie of falciparum and vivax malaria. Lancet 1995; 346: 1190-3.
14. Weiss WR, et al. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: Comparison with mefloquine, doxycycline, and chloroquine plus proguanil. J Infect Dis 1995; 171: 1569-75.
15. Baird JK, et al. Primaquine for prophylaxis against malaria among non-immune transmigrants in Iran Jaya, Indonesia. A J Trop Med Hyg 1995; 52: 479-84.
16. Gagneux OP, Blöchliger CU, Tanner M, Hatz CF. Malaria and casual sex: What travelers know and how they behave. J Travel Med 1996; 3: 14-21.
17. Behrens RH. Barrett J, Evereit T. The benefits of permethrin impregnated bed nets in preventing malaria. Abstracts of the 4th international conférence on travel medicine, Acapulco, April 23-27, 1995.